Mental health services have ‘considerable room for improvement’
September 28, 2009NHS, hc
The state of England's mental health services has been lambasted in a report from the Care Quality Commission (CQC). The …
Quality by design pilot extended by FDA
September 28, 2009NHS, hc
The US Food and Drug Administration has extended the deadline for groups wishing to take part in its quality-by-design pilot …
Chop and change for pharma production facilities
September 28, 2009Manufacturing and Production AZ, Teva
Quintiles opens Scottish central lab
September 28, 2009Research and Development Quintiles, Scotland
Quintiles has opened new facilities near Edinburgh, Scotland, that more than double its ability to provide central laboratory services to …
Abbott buys Solvay for $6.6 billion
September 28, 2009Sales and Marketing Abbott, Solvay, cystic fibrosis
Abbott is to buy the pharma division of Belgium-based Solvay for 4.5 billion euros ($6.6 billion) in cash.Solvay declared in …
MBAs: what can they do for your career?
September 25, 2009Business Services MBA, careers, training
A few years ago, getting an MBA was rare enough to seem like an automatic passport to the executive suite. …
Nexavar shows promise in breast cancer
September 24, 2009Sales and Marketing Cancer, Nexavar, breast cancer
Bayer’s Nexavar has been shown to significantly extend progression-free survival in patients with advanced breast cancer in a new phase …
Nycomed earmarks $96m for Russian manufacturing
September 24, 2009Manufacturing and Production Daxas, Nycomed, Russia
Swiss drugmaker Nycomed has provided more details of its plan to build a large-scale production facility in Russia.In July, Nycomed …
GlaxoSmithKline eyes Indian deal
September 23, 2009Sales and Marketing GSK, India
GlaxoSmithKline is said to be looking to buy an Indian firm, according to reports in one of the country's largest …
Janssen-Cilag wins NICE approval for psoriasis drug Stelara
September 23, 2009Sales and Marketing JJ, NICE, Stelara
NICE has approved Janssen-Cilag’s Stelara as a treatment option for adults with moderate to severe plaque psoriasis.Part of the process …
Gerresheimer invests further in plastic packaging
September 23, 2009Manufacturing and Production packaging
Gerresheimer has continued its expansion into the pharmaceutical plastic packaging sector with the construction of two new plants, one in …
GlaxoSmithKline to reform US medical education funding
September 23, 2009Medical Communications CME, US, ethics
GlaxoSmithKline has announced a major shift in its policy for paying for medical education programmes for doctors in the US.The …
Contract research news in brief
September 22, 2009Research and Development CRO
Pharmafocus' periodic round-up of developments in the contract research sector includes an acquisition and alliance for BioClinica, accreditations for ICON …
Pfizer and Icagen extend pain drug deal
September 22, 2009Research and Development Icagen, Pfizer
Pfizer has extended its existing deal with biotech Icagen, aimed at developing new treatments for pain and related disorders. Over …
AZ strikes drug development deal with Nektar Therapeutics
September 22, 2009Research and Development AZ, Nektar
AstraZeneca has licenced two anti-constipation drug development programmes from Nektar Therapeutics in a deal that could be worth more than …
Safety First
September 22, 2009Research and Development, Sales and Marketing EU, US, reg, safety
A series of high-profile drug withdrawals in recent years has brought safety concerns to the fore, prompting more rigorous monitoring …
Doctors’ leaders hit out at hospital funding proposals
September 21, 2009NHS, hc
The British Medical Association has hit out at health secretary Andy Burnham's ideas to link hospital funding to measures of …
Merck sells Merial share, but retains animal health option
September 21, 2009Sales and Marketing Merck, Merial, Sanofi, animal health
Merck & Co has got rid of its interest in animal health products company Merial prior to the merger with …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
